Article
Updating ACC preclinical models: characterization of two new patient-derived cell lines
2026-01-15
Abstract excerpt
AdrenoCortical Carcinoma (ACC) is an aggressive, rare and heterogenous malignancy, that requires diverse preclinical models. For this reason, the development of new cell lines is pivotal. Here we describe the development and characterization of two of them, SMAC-2 and SMAC-3, established from surgical specimens of ACC patients. The characterization included their mutational profiling, the evaluation of steroidogen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 630ee151-0c2f-5af1-929e-c9d81e8e12ef
- DOI
- 10.64898/2026.01.15.699554